(Q39591754)

13 September 2017

Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression (English)

1 reference

13 September 2017

1 reference

1 reference

Toshio Mori

4

0 references

Michael R Schön

object named as

Michael P Schön

8

0 references

author name string

Kai-Martin Thoms

1

1 reference

13 September 2017

Christiane Kuschal

2

1 reference

13 September 2017

Elke Oetjen

3

1 reference

13 September 2017

Nobuhiko Kobayashi

5

1 reference

13 September 2017

Petra Laspe

6

1 reference

13 September 2017

Lars Boeckmann

7

1 reference

13 September 2017

Steffen Emmert

9

1 reference

13 September 2017

1 March 2011

1 reference

13 September 2017

Experimental Dermatology

1 reference

13 September 2017

20

1 reference

13 September 2017

3

1 reference

13 September 2017

232-236

1 reference

Malignancy after transplantation

13 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

[Skin diseases in organ transplant patients]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Immunosuppressants and skin cancer in transplant patients: focus on rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Branches on the alpha-C atom of cyclosporin A residue 3 result in direct calcineurin inhibition and rapid cyclophilin 18 binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

The immunosuppressive drugs cyclosporin A and tacrolimus inhibit membrane depolarization-induced CREB transcriptional activity at the coactivator level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

mTOR inhibitors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Nucleotide excision repair and human syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Lessons learned from DNA repair defective syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Cyclosporin-A suppresses p53-dependent repair DNA synthesis and apoptosis following ultraviolet-B irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Simultaneous establishment of monoclonal antibodies specific for either cyclobutane pyrimidine dimer or (6-4)photoproduct from the same mouse immunized with ultraviolet-irradiated DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

The mechanism of action of cyclosporin A and FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

DNA repair in mononuclear cells: role of serine/threonine phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Calcineurin inhibitors reduce nuclear localization of transcription factor NFAT in UV-irradiated keratinocytes and reduce DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Phosphorylation of XPB helicase regulates TFIIH nucleotide excision repair activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

PP2A regulates ionizing radiation-induced apoptosis through Ser46 phosphorylation of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

Xenotransplantation and Its Implications: Background Information for the Press

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01213.X

10.1111/J.1600-0625.2010.01213.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference